Ardent Health Partners (NYSE:ARDT) Given “Overweight” Rating at Stephens

Stephens reiterated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a research note released on Thursday,Benzinga reports. They currently have a $22.00 price objective on the stock.

Other equities analysts have also recently issued reports about the stock. Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price target for the stock from $22.00 to $19.00 in a report on Wednesday, November 6th. Truist Financial cut their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $23.00 price target on shares of Ardent Health Partners in a research note on Thursday, November 14th. Morgan Stanley lowered their price target on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Finally, Leerink Partners raised their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $21.36.

Ardent Health Partners Stock Performance

Ardent Health Partners stock opened at $15.10 on Thursday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The stock’s fifty day moving average price is $15.25 and its two-hundred day moving average price is $16.85. Ardent Health Partners has a one year low of $13.63 and a one year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion. Analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current year.

Institutional Trading of Ardent Health Partners

Hedge funds and other institutional investors have recently made changes to their positions in the company. Squarepoint Ops LLC boosted its position in Ardent Health Partners by 1.8% during the 4th quarter. Squarepoint Ops LLC now owns 101,798 shares of the company’s stock worth $1,739,000 after buying an additional 1,798 shares during the period. State of Wyoming raised its stake in shares of Ardent Health Partners by 123.3% during the fourth quarter. State of Wyoming now owns 31,693 shares of the company’s stock valued at $541,000 after acquiring an additional 17,499 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health Partners during the fourth quarter worth $27,000. Point72 Asset Management L.P. grew its stake in shares of Ardent Health Partners by 7.9% in the fourth quarter. Point72 Asset Management L.P. now owns 1,609,720 shares of the company’s stock worth $27,494,000 after purchasing an additional 117,421 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its holdings in Ardent Health Partners by 220.6% in the fourth quarter. Nuveen Asset Management LLC now owns 169,475 shares of the company’s stock valued at $2,895,000 after purchasing an additional 116,610 shares during the period.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.